ABSTRACT
Cancer is a complex and multifactorial disease characterized by uncontrolled cell growth and is one of the main causes of death in the world. This work aimed to evaluate a small series of 10 different indole-thiosemicarbazone compounds as potential antitumor agents. This is a pioneering study. For this, the antioxidant and cytotoxic capacity against normal and tumor cells was evaluated. The results showed that the compounds were able to promote moderate to low antioxidant activity for the ABTS radical scavenging assay. ADMET in silico assays showed that the compounds exhibited good oral bioavailability. As for toxicity, they were able to promote low cytotoxicity against normal cells, in addition to not being hemolytic. The compounds showed promising in vitro antitumor activity against the T47D, MCF-7, Jurkat and DU-145 strains, not being able to inhibit the growth of the Hepg2 strain. Through this in vitro study, it can be concluded that the compounds are potential candidates for antitumor agents.
Subject(s)
Antineoplastic Agents , Antioxidants , Indoles , Thiosemicarbazones , Humans , Thiosemicarbazones/pharmacology , Thiosemicarbazones/chemistry , Thiosemicarbazones/pharmacokinetics , Indoles/pharmacology , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Antioxidants/pharmacology , Cell Line, Tumor , Computer Simulation , Drug Screening Assays, Antitumor , Cell Proliferation/drug effectsABSTRACT
Considering the promising previous results on the remarkable activity exhibited by cobalt(III) and manganese(II) thiosemicarbazone compounds as antibacterial agents, the present study aimed to prepare and then evaluate the antibacterial activity of two different types of Cu(II) complexes based on a 2-acetylpyridine-N(4)-methyl-thiosemicarbazone ligand (Hatc-Me), a monomer complex [CuCl(atc-Me)] and a novel dinuclear complex [{Cu(µ-atc-Me)}2µ-SO4]. The compounds were characterized by infrared spectra, ultraviolet visible and CHN elemental analysis. In addition, the crystalline structures of the complexes were determined by single-crystal X-ray diffraction. In both cases, the Schiff base ligand coordinated in a tridentate mode via the pyridine nitrogen, imine nitrogen and sulfur atoms. The two Cu(II) atoms in the dimer are five coordinate, consisting of three NNS-donor atoms from the thiosemicarbazone ligand connected by a sulfate bridge. The Hirshfeld surface and energy framework of the complexes were additionally analyzed to verify the intermolecular interactions. The biological activity of the Cu(II) salts, the free ligand and its Cu(II) complexes was evaluated against six strains of mycobacteria including Mycobacterium tuberculosis. The complexes showed promising results as antibacterial agents for M. avium and M. tuberculosis, which ranged from 6.12 to 12.73 µM. Furthermore, molecular docking analysis was performed and the binding energy of the docked compound [{Cu(µ-atc-Me)}2µ-SO4] with M. tuberculosis and M. avium strains were extremely favorable (-11.11 and - 14.03 kcal/mol, respectively). The in silico results show that the complexes are potential candidates for the development of new antimycobacterial drugs.
Subject(s)
Antitubercular Agents/pharmacology , Coordination Complexes/pharmacology , Thiosemicarbazones/pharmacology , Antitubercular Agents/chemical synthesis , Antitubercular Agents/metabolism , Antitubercular Agents/pharmacokinetics , Bacterial Proteins/metabolism , Coordination Complexes/chemical synthesis , Coordination Complexes/metabolism , Coordination Complexes/pharmacokinetics , Copper/chemistry , Ligands , Microbial Sensitivity Tests , Molecular Docking Simulation , Molecular Structure , Mycobacterium avium/drug effects , Mycobacterium kansasii/drug effects , Mycobacterium tuberculosis/drug effects , Protein Binding , Structure-Activity Relationship , Thermodynamics , Thiosemicarbazones/chemical synthesis , Thiosemicarbazones/metabolism , Thiosemicarbazones/pharmacokineticsABSTRACT
The present work aimed to carry out in vitro biological assays of indol-3-yl derivatives thiosemicarbazones (2a-e) and 4-thiazolidinones (3a-d) against juvenile and adult worms of S. mansoni, as well as the in silico determination of pharmacokinetic parameters for the prediction of the oral bioavailability of these derivatives. All compounds were initially screened at a concentration of 200⯵M against S. mansoni adult worms and the results evidenced the good activity of compounds 2b, 2d and 3b, which caused 100% mortality after 24, 48 and 72â¯h, respectively. Subsequent studies with these same compounds revealed that compound 2b was able to reduce the viability of the parasites by 85% and 83% at concentrations of 200 and 100⯵M, respectively. In relation to the juvenile worms, all compounds (2b, 2d and 3b) were able to cause mortality, but compound 2b demonstrated better activity causing 100% mortality in 48â¯h. Additionally, it was possible to observe reduction in the viability of juvenile worms of 85%, 81% and 64% at concentrations of 200, 100 and 50⯵M, respectively. Several ultrastructural damages were observed when adult and juvenile S. mansoni worms were exposed to compound 2b (200⯵M) that was characterized by extensive destruction by the integument, which may justify the mortality rate of cultured parasites. In the DNA interaction assay, fragmentation of the genetic material of adult worms when treated with compound 2b (200⯵M) was evidenced, indicating the apoptosis process as mechanism of parasite death. Regarding pharmacokinetic properties, all derivatives are according to the required parameters, predicting good oral bioavailability for the studied compounds. The results presented in this study reveal the good activity of compound 2b in both adult and juvenile worms of S. mansoni, pointing this compound as promising in the development of further studies on schistosomicidal activity.
Subject(s)
Schistosoma mansoni/drug effects , Thiosemicarbazones/pharmacology , Thiosemicarbazones/pharmacokinetics , Animals , Helminths/drug effects , Schistosomicides/pharmacokinetics , Schistosomicides/pharmacologyABSTRACT
Cisplatin and its derivatives are the main metallodrugs used in cancer therapy. However, low selectivity, toxicity and drug resistance are associated with their use. The zinc(II) (Zn(II)) thiosemicarbazone complexes [Zn(atc-Et)2] (1) and [Zn(atc-Ph)2] (2) (atc-R: monovalent anion of 2-acetylpyridine N4-R-thiosemicarbazone) were synthesized and fully characterized in the solid state and in solution via elemental analysis, Fourier transform infrared (FTIR), ultraviolet-visible (UV-Vis) and proton nuclear magnetic resonance (¹H NMR) spectroscopy, conductometry and single-crystal X-ray diffraction. The cytotoxicity of these complexes was evaluated in the HepG2, HeLa, MDA-MB-231, K-562, DU 145 and MRC-5 cancer cell lines. The strongest antiproliferative results were observed in MDA-MB-231 and HepG2 cells, in which these complexes displayed significant selective toxicity (3.1 and 3.6, respectively) compared with their effects on normal MRC-5 cells. In vivo studies were performed using an alternative model (Artemia salina L.) to assure the safety of these complexes, and the results were confirmed using a conventional model (BALB/c mice). Finally, tests of oral bioavailability showed maximum plasma concentrations of 3029.50 µg/L and 1191.95 µg/L for complexes 1 and 2, respectively. According to all obtained results, both compounds could be considered as prospective antiproliferative agents that warrant further research.
Subject(s)
Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacokinetics , Thiosemicarbazones/chemical synthesis , Thiosemicarbazones/pharmacokinetics , Zinc/chemistry , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/chemistry , Artemia , Biological Availability , Cell Line, Tumor , Cell Proliferation/drug effects , HeLa Cells , Hep G2 Cells , Humans , In Vitro Techniques , Mice , Molecular Structure , Thiosemicarbazones/administration & dosage , Thiosemicarbazones/chemistry , Toxicity Tests, AcuteABSTRACT
Como modelaciòn de la actividad protectora de la superoxidodismutasa, se estudiò cinéticamente el sistema O2 Cu (II) mediante la determinaciòn de seudoconstantes de velocidad en la reacciòn de 17 compuestos de algunas tio y semicarbazonas de cobre (II) con el radical superóxido. Se correlacionaron estas seudoconstantes de velocidad con la citotoxidad in vitro de los 17 compuestos, así como de cada familia de compuestos por separado. La mejor correlaciòn se logró en el caso de las semicarbazonas. Las tiosemicarbazonas, por su parte, resultaron ser las más citotóxicas. Se interpretan estos resultados a partir de las características del enlace quìmico
Subject(s)
In Vitro Techniques , Superoxides/pharmacokinetics , Semicarbazones/pharmacokinetics , Thiosemicarbazones/pharmacokinetics , Antineoplastic Combined Chemotherapy Protocols/toxicityABSTRACT
Como modelaciòn de la actividad protectora de la superoxidodismutasa, se estudiò cinéticamente el sistema O2 Cu (II) mediante la determinaciòn de seudoconstantes de velocidad en la reacciòn de 17 compuestos de algunas tio y semicarbazonas de cobre (II) con el radical superóxido. Se correlacionaron estas seudoconstantes de velocidad con la citotoxidad in vitro de los 17 compuestos, así como de cada familia de compuestos por separado. La mejor correlaciòn se logró en el caso de las semicarbazonas. Las tiosemicarbazonas, por su parte, resultaron ser las más citotóxicas. Se interpretan estos resultados a partir de las características del enlace quìmico